Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism

被引:25
作者
Hage, Mirella P. [1 ]
Salti, Ibrahim [1 ]
El-Hajj Fuleihan, Ghada [1 ]
机构
[1] Amer Univ Beirut, Med Ctr, WHO Collaborating Ctr Metab Bone Disorders, Dept Internal Med,Div Endocrinol, Beirut, Lebanon
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2012年 / 61卷 / 06期
关键词
MILD PRIMARY HYPERPARATHYROIDISM; BONE-MINERAL DENSITY; SECONDARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; ORAL ALENDRONATE; CARCINOMA; CALCIUM; REOPERATION; PARATHYROIDECTOMY; DIPHOSPHONATE;
D O I
10.1016/j.metabol.2011.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:762 / 775
页数:14
相关论文
共 65 条
  • [1] REGULATION OF CALCIUM-PARATHYROID HORMONE FEEDBACK IN PRIMARY HYPERPARATHYROIDISM - EFFECTS OF BISPHOSPHONATE TREATMENT
    ADAMI, S
    MIAN, M
    BERTOLDO, F
    ROSSINI, M
    JAYAWERRA, P
    ORIORDAN, JLH
    LOCASCIO, V
    [J]. CLINICAL ENDOCRINOLOGY, 1990, 33 (03) : 391 - 397
  • [2] AKERSTROM G, 1988, ACTA CHIR SCAND, V154, P549
  • [3] AKERSTROM G, 1984, SURGERY, V95, P14
  • [4] Parathyromatosis as cause of recurrent secondary hyperparathyroidism: A cytologic diagnosis
    Baloch, ZW
    Fraker, D
    LiVolsi, VA
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2001, 25 (06) : 403 - 405
  • [5] Bilezikian J., 2001, The parathyroids, V2nd
  • [6] Bilezikian JP., 2001, PARATHYROIDS BASIC
  • [7] BRUINING HA, 1987, SURGERY, V101, P562
  • [8] Operative Failures After Parathyroidectomy for Hyperparathyroidism The Influence of Surgical Volume
    Chen, Herbert
    Wang, Tracy S.
    Yen, Tina W. F.
    Doffek, Kara
    Krzywda, Elizabeth
    Schaefer, Sarah
    Sippel, Rebecca S.
    Wilson, Stuart D.
    [J]. ANNALS OF SURGERY, 2010, 252 (04) : 691 - 694
  • [9] Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism
    Chow, CC
    Chan, WB
    Li, JKY
    Chan, NN
    Chan, MHM
    Ko, GTC
    Lo, KW
    Cockram, CS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 581 - 587
  • [10] COHN K, 1985, SURGERY, V98, P1095